Search research articles
Contact Us
Filters
Showing results (21-30 of 379) with videos related to
Page
of 38
Sort By:
Progress in Retinal and Eye Research
|
July 3, 2026
Visual arrestin-1: how did we learn what we know today about this protein?
Vsevolod V Gurevich, Eugenia V Gurevich
Advances in Protein Chemistry and Structural Biology
|
April 22, 2020
Targeting arrestin interactions with its partners for therapeutic purposes
Vsevolod V Gurevich, Eugenia V Gurevich
Trends in Pharmacological Sciences
|
April 23, 2004
The molecular acrobatics of arrestin activation
Vsevolod V Gurevich, Eugenia V Gurevich
The EMBO Journal
|
February 8, 2014
Arrestin makes T cells stop and become active
Vsevolod V Gurevich, Eugenia V Gurevich
British Journal of Pharmacology
|
January 10, 2015
Beyond traditional pharmacology: new tools and approaches
E V Gurevich, V V Gurevich
Current Protocols in Pharmacology
|
December 3, 2014
Overview of different mechanisms of arrestin-mediated signaling
Vsevolod V Gurevich, Eugenia V Gurevich
Pharmacology & Therapeutics
|
March 24, 2020
Biased GPCR signaling: Possible mechanisms and inherent limitations
Vsevolod V Gurevich, Eugenia V Gurevich
Molecular and Cellular Endocrinology
|
February 1, 2019
The structural basis of the arrestin binding to GPCRs
Vsevolod V Gurevich, Eugenia V Gurevich
Progress in Molecular Biology and Translational Science
|
February 4, 2019
Arrestin mutations: Some cause diseases, others promise cure
Vsevolod V Gurevich, Eugenia V Gurevich
Cellular and Molecular Life Sciences : CMLS
|
August 19, 2019
Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies
Vsevolod V Gurevich, Eugenia V Gurevich
Page
of 38
Search research articles
Search
Showing results (21-30 of 379) with videos related to
Sort By:
Page
of 38
Progress in Retinal and Eye Research
|
July 3, 2026
Visual arrestin-1: how did we learn what we know today about this protein?
Vsevolod V Gurevich, Eugenia V Gurevich
Advances in Protein Chemistry and Structural Biology
|
April 22, 2020
Targeting arrestin interactions with its partners for therapeutic purposes
Vsevolod V Gurevich, Eugenia V Gurevich
Trends in Pharmacological Sciences
|
April 23, 2004
The molecular acrobatics of arrestin activation
Vsevolod V Gurevich, Eugenia V Gurevich
The EMBO Journal
|
February 8, 2014
Arrestin makes T cells stop and become active
Vsevolod V Gurevich, Eugenia V Gurevich
British Journal of Pharmacology
|
January 10, 2015
Beyond traditional pharmacology: new tools and approaches
E V Gurevich, V V Gurevich
Current Protocols in Pharmacology
|
December 3, 2014
Overview of different mechanisms of arrestin-mediated signaling
Vsevolod V Gurevich, Eugenia V Gurevich
Pharmacology & Therapeutics
|
March 24, 2020
Biased GPCR signaling: Possible mechanisms and inherent limitations
Vsevolod V Gurevich, Eugenia V Gurevich
Molecular and Cellular Endocrinology
|
February 1, 2019
The structural basis of the arrestin binding to GPCRs
Vsevolod V Gurevich, Eugenia V Gurevich
Progress in Molecular Biology and Translational Science
|
February 4, 2019
Arrestin mutations: Some cause diseases, others promise cure
Vsevolod V Gurevich, Eugenia V Gurevich
Cellular and Molecular Life Sciences : CMLS
|
August 19, 2019
Plethora of functions packed into 45 kDa arrestins: biological implications and possible therapeutic strategies
Vsevolod V Gurevich, Eugenia V Gurevich
Page
of 38